Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years. CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70...
Gespeichert in:
| Veröffentlicht in: | Medical journal of Australia 2006-11, Vol.185 (10), p.549-556 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 556 |
|---|---|
| container_issue | 10 |
| container_start_page | 549 |
| container_title | Medical journal of Australia |
| container_volume | 185 |
| creator | Krum, Henry Jelinek, Michael V Stewart, Simon Sindone, Andrew Atherton, John J Hawkes, Anna L |
| description | Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years.
CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years).
Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two‐thirds of cases) and idiopathic dilated cardiomyopathy (around 5%–10% of cases).
Diagnosis is based on clinical features, chest x‐ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B‐type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms.
Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival. |
| doi_str_mv | 10.5694/j.1326-5377.2006.tb00690.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68175811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1192153241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4320-54d71e1ab5a993897326ca171333e5b910816ab0a6d38c5dd50d8dbd7f398cc33</originalsourceid><addsrcrecordid>eNqVkU1v1DAQhi0EokvhLyCrEpxI8EccJ9xWFRRQEReQuFmOPWG9SuxgJ_349zhsRCVuXOyx5pnxO_MidEFJKeq2enssKWd1IbiUJSOkLucuny0p7x6h3d_UY7QjhIlCsvbHGXqW0jE_qWDyKTqjklLR1nKH_NXiLAzOQ8J9iHg-AJ4i3ICfXfBvsIUZzBpi7S0etdc_YcxJHHo8QZgGwLduPmBziME7gw-g44x77YYlAnYe75c0Rz04jVepz9GTXg8JXmz3Ofr-4f23y4_F9derT5f768JUnJFCVFZSoLoTum1508o8lNFZNeccRNdS0tBad0TXljdGWCuIbWxnZc_bxhjOz9HrU98phl8LpFmNLhkYBu0hLEnVDZWioTSDF_-Ax7BEn7UpxoWsK1qJDL07QSaGlCL0aopu1PFeUaJWS9RRrXtX697VOqfaLFF3ufjl9sPSjWAfSjcPMvBqA3Qyeuij9salB67hhMl6lbo_cbdugPv_kKC-fN6zPzH_DdBAqM8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235764145</pqid></control><display><type>article</type><title>Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Krum, Henry ; Jelinek, Michael V ; Stewart, Simon ; Sindone, Andrew ; Atherton, John J ; Hawkes, Anna L</creator><creatorcontrib>Krum, Henry ; Jelinek, Michael V ; Stewart, Simon ; Sindone, Andrew ; Atherton, John J ; Hawkes, Anna L ; CHF Guidelines Core Writers</creatorcontrib><description>Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years.
CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years).
Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two‐thirds of cases) and idiopathic dilated cardiomyopathy (around 5%–10% of cases).
Diagnosis is based on clinical features, chest x‐ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B‐type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms.
Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.</description><identifier>ISSN: 0025-729X</identifier><identifier>EISSN: 1326-5377</identifier><identifier>DOI: 10.5694/j.1326-5377.2006.tb00690.x</identifier><identifier>PMID: 17115967</identifier><identifier>CODEN: MJAUAJ</identifier><language>eng</language><publisher>Sydney: Australasian Medical Publishing Company</publisher><subject>Aftercare ; Aged ; Aged, 80 and over ; Asymptomatic ; Australia ; Biological and medical sciences ; Cardiac Pacing, Artificial ; Cardiomyopathy ; Cardiovascular disease ; Cardiovascular diseases ; Coronary Disease - surgery ; Costs ; General aspects ; Health care expenditures ; Heart failure ; Heart Failure - diagnosis ; Heart Failure - drug therapy ; Heart Failure - prevention & control ; Hospitals ; Humans ; Hypertension ; Ischemia ; Medical sciences ; Middle Aged ; Mortality ; Older people ; Palliative Care ; Peptides ; Physical Examination ; Prevention and actions ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Ventricular Dysfunction, Left - drug therapy ; Ventricular Dysfunction, Left - prevention & control</subject><ispartof>Medical journal of Australia, 2006-11, Vol.185 (10), p.549-556</ispartof><rights>2006 AMPCo Pty Ltd. All rights reserved</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Australasian Medical Publishing Company Proprietary, Ltd. Nov 20, 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4320-54d71e1ab5a993897326ca171333e5b910816ab0a6d38c5dd50d8dbd7f398cc33</citedby><cites>FETCH-LOGICAL-c4320-54d71e1ab5a993897326ca171333e5b910816ab0a6d38c5dd50d8dbd7f398cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.5694%2Fj.1326-5377.2006.tb00690.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.5694%2Fj.1326-5377.2006.tb00690.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18302761$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17115967$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krum, Henry</creatorcontrib><creatorcontrib>Jelinek, Michael V</creatorcontrib><creatorcontrib>Stewart, Simon</creatorcontrib><creatorcontrib>Sindone, Andrew</creatorcontrib><creatorcontrib>Atherton, John J</creatorcontrib><creatorcontrib>Hawkes, Anna L</creatorcontrib><creatorcontrib>CHF Guidelines Core Writers</creatorcontrib><title>Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006</title><title>Medical journal of Australia</title><addtitle>Med J Aust</addtitle><description>Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years.
CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years).
Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two‐thirds of cases) and idiopathic dilated cardiomyopathy (around 5%–10% of cases).
Diagnosis is based on clinical features, chest x‐ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B‐type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms.
Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.</description><subject>Aftercare</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Asymptomatic</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Cardiac Pacing, Artificial</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Coronary Disease - surgery</subject><subject>Costs</subject><subject>General aspects</subject><subject>Health care expenditures</subject><subject>Heart failure</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - prevention & control</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Older people</subject><subject>Palliative Care</subject><subject>Peptides</subject><subject>Physical Examination</subject><subject>Prevention and actions</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Ventricular Dysfunction, Left - drug therapy</subject><subject>Ventricular Dysfunction, Left - prevention & control</subject><issn>0025-729X</issn><issn>1326-5377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkU1v1DAQhi0EokvhLyCrEpxI8EccJ9xWFRRQEReQuFmOPWG9SuxgJ_349zhsRCVuXOyx5pnxO_MidEFJKeq2enssKWd1IbiUJSOkLucuny0p7x6h3d_UY7QjhIlCsvbHGXqW0jE_qWDyKTqjklLR1nKH_NXiLAzOQ8J9iHg-AJ4i3ICfXfBvsIUZzBpi7S0etdc_YcxJHHo8QZgGwLduPmBziME7gw-g44x77YYlAnYe75c0Rz04jVepz9GTXg8JXmz3Ofr-4f23y4_F9derT5f768JUnJFCVFZSoLoTum1508o8lNFZNeccRNdS0tBad0TXljdGWCuIbWxnZc_bxhjOz9HrU98phl8LpFmNLhkYBu0hLEnVDZWioTSDF_-Ax7BEn7UpxoWsK1qJDL07QSaGlCL0aopu1PFeUaJWS9RRrXtX697VOqfaLFF3ufjl9sPSjWAfSjcPMvBqA3Qyeuij9salB67hhMl6lbo_cbdugPv_kKC-fN6zPzH_DdBAqM8</recordid><startdate>20061120</startdate><enddate>20061120</enddate><creator>Krum, Henry</creator><creator>Jelinek, Michael V</creator><creator>Stewart, Simon</creator><creator>Sindone, Andrew</creator><creator>Atherton, John J</creator><creator>Hawkes, Anna L</creator><general>Australasian Medical Publishing Company</general><general>Australasian Medical Publishing Company Proprietary, Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20061120</creationdate><title>Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006</title><author>Krum, Henry ; Jelinek, Michael V ; Stewart, Simon ; Sindone, Andrew ; Atherton, John J ; Hawkes, Anna L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4320-54d71e1ab5a993897326ca171333e5b910816ab0a6d38c5dd50d8dbd7f398cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aftercare</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Asymptomatic</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Cardiac Pacing, Artificial</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Coronary Disease - surgery</topic><topic>Costs</topic><topic>General aspects</topic><topic>Health care expenditures</topic><topic>Heart failure</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - prevention & control</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Older people</topic><topic>Palliative Care</topic><topic>Peptides</topic><topic>Physical Examination</topic><topic>Prevention and actions</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Ventricular Dysfunction, Left - drug therapy</topic><topic>Ventricular Dysfunction, Left - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krum, Henry</creatorcontrib><creatorcontrib>Jelinek, Michael V</creatorcontrib><creatorcontrib>Stewart, Simon</creatorcontrib><creatorcontrib>Sindone, Andrew</creatorcontrib><creatorcontrib>Atherton, John J</creatorcontrib><creatorcontrib>Hawkes, Anna L</creatorcontrib><creatorcontrib>CHF Guidelines Core Writers</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Medical journal of Australia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krum, Henry</au><au>Jelinek, Michael V</au><au>Stewart, Simon</au><au>Sindone, Andrew</au><au>Atherton, John J</au><au>Hawkes, Anna L</au><aucorp>CHF Guidelines Core Writers</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006</atitle><jtitle>Medical journal of Australia</jtitle><addtitle>Med J Aust</addtitle><date>2006-11-20</date><risdate>2006</risdate><volume>185</volume><issue>10</issue><spage>549</spage><epage>556</epage><pages>549-556</pages><issn>0025-729X</issn><eissn>1326-5377</eissn><coden>MJAUAJ</coden><abstract>Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years.
CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years).
Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two‐thirds of cases) and idiopathic dilated cardiomyopathy (around 5%–10% of cases).
Diagnosis is based on clinical features, chest x‐ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B‐type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms.
Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.</abstract><cop>Sydney</cop><pub>Australasian Medical Publishing Company</pub><pmid>17115967</pmid><doi>10.5694/j.1326-5377.2006.tb00690.x</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-729X |
| ispartof | Medical journal of Australia, 2006-11, Vol.185 (10), p.549-556 |
| issn | 0025-729X 1326-5377 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68175811 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aftercare Aged Aged, 80 and over Asymptomatic Australia Biological and medical sciences Cardiac Pacing, Artificial Cardiomyopathy Cardiovascular disease Cardiovascular diseases Coronary Disease - surgery Costs General aspects Health care expenditures Heart failure Heart Failure - diagnosis Heart Failure - drug therapy Heart Failure - prevention & control Hospitals Humans Hypertension Ischemia Medical sciences Middle Aged Mortality Older people Palliative Care Peptides Physical Examination Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Ventricular Dysfunction, Left - drug therapy Ventricular Dysfunction, Left - prevention & control |
| title | Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A25%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guidelines%20for%20the%20prevention,%20detection%20and%20management%20of%20people%20with%20chronic%20heart%20failure%20in%20Australia%202006&rft.jtitle=Medical%20journal%20of%20Australia&rft.au=Krum,%20Henry&rft.aucorp=CHF%20Guidelines%20Core%20Writers&rft.date=2006-11-20&rft.volume=185&rft.issue=10&rft.spage=549&rft.epage=556&rft.pages=549-556&rft.issn=0025-729X&rft.eissn=1326-5377&rft.coden=MJAUAJ&rft_id=info:doi/10.5694/j.1326-5377.2006.tb00690.x&rft_dat=%3Cproquest_cross%3E1192153241%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=235764145&rft_id=info:pmid/17115967&rfr_iscdi=true |